V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006437 | 300004529 | 1.75 | 66 | Disease modification (D) | 2015-10-04 | 2015-10-07 | CAP + RT | N | Y | 300016555 | CARBOPLATIN + RT |
| 300006438 | 300004530 | 1.66 | 51.5 | Curative (C) | 2013-04-19 | 2013-04-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300016555 | IRINOTECAN |
| 300006439 | 300004530 | 1.76 | 56 | Curative (C) | 2016-03-23 | 2016-04-17 | Cisplatin +Fluorouracil (3 wk) | N | Y | 300016555 | CETUXIMAB + RT |
| 300006440 | 300004531 | null | 62.1 | Palliative (P) | 2017-01-20 | 2017-01-21 | null | 02 | N | 300016562 | OXALIPLATIN + MDG |
| 300006441 | 300004532 | 1.71 | 62 | Palliative (P) | 2013-07-20 | 2013-08-23 | Trial Unspecified | N | N | 300016570 | CISPLATIN + DOX + ETOPOSIDE |
| 300006442 | 300004532 | 1.08 | 73.2 | Curative (C) | 2018-02-04 | 2018-02-19 | Capecitabine + Oxaliplatin 21day | N | N | 300016570 | IRINOTECAN + MDG |
| 300006444 | 300004535 | 1.6 | 94.7 | Curative (C) | 2016-08-18 | 2016-08-18 | Oxaliplatin + Modified de Gramont | 02 | null | 300016586 | CARBOPLATIN + RT |
| 300006445 | 300004536 | 1.77 | 55.9 | Palliative (P) | 2016-12-05 | 2016-12-11 | Trial Unspecified | 2 | N | 300016591 | IPILIMUMAB |
| 300006446 | 300006879 | 1.6 | null | Neo-adjuvant (N) | null | 2016-06-26 | Carboplatin + Paclitaxel (3 weekly) | null | null | 300016596 | CISPLATIN + FLUOROURACIL |
| 300006447 | 300004538 | 1.6 | 66.1 | Neo-adjuvant (N) | 2017-08-07 | 2017-09-04 | Carboplatin AUC 6 - 10 | 02 | N | 300016598 | CISPLATIN + FLUOROURACIL |
| 300006448 | 300004539 | null | 0 | Curative (C) | 2015-06-14 | 2015-07-17 | CARBOPLATIN + RT | N | Y | 300016598 | GEMCITABINE + RT |
| 300006449 | 300004540 | 1.88 | 85.3 | Neo-adjuvant (N) | 2012-09-04 | 2013-03-26 | Capecitabine + Oxaliplatin 21day | Y | N | 300016605 | CARBOPLATIN + PACLITAXEL |
| 300006450 | 300004541 | 1.74 | 90 | Curative (C) | 2014-06-18 | 2014-06-28 | NAB PACLITAXEL | 02 | N | 300016607 | CETUXIMAB + CISPLATIN + FU |
| 300006451 | 300004541 | 1.75 | 92.5 | Neo-adjuvant (N) | 2014-07-22 | 2014-07-22 | OXALIPLATIN | 2 | null | 300016607 | CAPECITABINE + STREPTOZOCIN |
| 300006452 | 300004542 | 1.9 | 55.2 | Curative (C) | 2013-08-31 | 2013-09-20 | Trial Unspecified | null | null | 300016624 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006453 | 300004544 | 1.8 | 80.4 | Neo-adjuvant (N) | 2017-01-26 | 2017-02-18 | IMATINIB | 02 | N | 300016624 | FLUOROURACIL + MITOMYCIN |
| 300006454 | 300004545 | 1.63 | 70.5 | Curative (C) | 2013-03-11 | 2013-03-15 | Capecitabine | 02 | N | 300016626 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300006455 | 300004546 | null | 88 | Curative (C) | 2014-08-28 | 2014-08-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300016630 | CAPECITABINE + GEMCITABINE |
| 300006456 | 300004546 | 1.71 | 54.2 | Curative (C) | null | 2013-11-03 | FLUOROURACIL + OXALIPLATIN | N | N | 300016630 | CARBO + FLUOROURACIL |
| 300006457 | 300004548 | 1.55 | null | Neo-adjuvant (N) | 2017-07-12 | 2017-07-18 | Cisplatin 7 day | N | N | 300016636 | CAPECITABINE |
| 300006458 | 300004551 | 1.7 | 63.75 | Neo-adjuvant (N) | 2015-10-13 | 2015-10-13 | Docetaxel 75mg/m2 (21 day) | 1 | N | 300016644 | OXALIPLATIN + MDG |
| 300006459 | 300004552 | null | 51.7 | Adjuvant (A) | 2013-11-15 | 2013-11-27 | Trial Unspecified | N | N | 300016644 | BEVACIZUMAB |
| 300006460 | 300004553 | 1.6 | 65.8 | Neo-adjuvant (N) | 2017-12-19 | 2017-12-26 | GemCarbo Days 1+8 | N | N | 300016647 | OXALIPLATIN + MDG |
| 300006461 | 300004554 | 1.58 | 89.9 | Curative (C) | 2013-11-07 | 2013-11-15 | PEMBROLIZUMAB | Y | N | 300016665 | CETUXIMAB |
| 300006462 | 300004554 | 1.65 | null | Curative (C) | 2015-06-27 | 2015-07-18 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 2 | N | 300016665 | CAPECITABINE + RT |
| 300006463 | 300004555 | null | 58.6 | Curative (C) | null | 2015-09-05 | Cetuximab + Radiotherapy Maint | N | N | 300016681 | CAPECITABINE |
| 300006464 | 300004555 | 1.77 | 55 | null | 2014-10-26 | 2014-11-10 | CETUXIMAB + RT | N | Y | 300016681 | CETUXIMAB |
| 300006465 | 300004556 | 1.55 | 73.3 | Palliative (P) | 2018-06-01 | 2018-06-12 | CompARE Trial | Y | N | 300016704 | CARBOPLATIN |
| 300006466 | 300007758 | 1.73 | 58.8 | null | 2014-06-20 | 2014-07-05 | CISPLATIN + FLUOROURACIL | 1 | N | 300016712 | CAV |
| 300006467 | 300004557 | 1.6 | 62.9 | Radical (R) | 2017-07-02 | 2017-07-23 | CARBOPLATIN + FLUOROURACIL | N | N | 300016724 | LENALIDOMIDE |
| 300006468 | 300004559 | 1.55 | 72.1 | Neo-adjuvant (N) | 2017-07-25 | 2017-08-09 | Capecitabine | N | null | 300016735 | CETUXIMAB + RT |
| 300006469 | 300004563 | null | 55.2 | Palliative (P) | 2014-02-18 | 2014-02-25 | Cisplatin +Fluorouracil (2 wk) | 01 | N | 300016740 | TOTEM TRIAL |
| 300006470 | 300004566 | 1.7 | 66 | Palliative (P) | 2014-06-13 | 2014-07-04 | TOTEM TRIAL | 2 | N | 300016741 | NIVOLUMAB |
| 300006471 | 300004566 | 1.9 | 110 | Neo-adjuvant (N) | 2013-09-02 | 2013-09-02 | FLUOROURACIL | 2 | N | 300016741 | CARBOPLATIN |
| 300006474 | 300004569 | null | 93.2 | Neo-adjuvant (N) | 2011-05-26 | 2013-06-26 | CETUXIMAB + RT | N | N | 300016761 | CAPECITABINE + OXALIPLATIN |
| 300006475 | 300004570 | 1.76 | 70.4 | Curative (C) | 2014-06-28 | 2014-07-12 | CAPECITABINE + OXALIPLATIN | N | Y | 300016769 | CETUXIMAB + RT |
| 300006476 | 300004572 | 1.62 | 58.1 | Curative (C) | 2014-01-07 | 2014-02-07 | Irinotecan + Modified De Gramont | N | N | 300016769 | CAPECITABINE + RT |
| 300006477 | 300004572 | 1.77 | 58.7 | Curative (C) | 2016-03-04 | 2016-03-29 | Capecitabine | N | N | 300016769 | CETUXIMAB |
| 300006478 | 300004573 | 1.68 | 51.9 | Neo-adjuvant (N) | 2014-05-26 | 2014-05-26 | Irinotecan + Modified De Gramont | N | N | 300016795 | CARBOPLATIN + PACLITAXEL |
| 300006479 | 300004573 | 1.58 | null | Neo-adjuvant (N) | 2018-02-26 | 2018-02-28 | Ipilimumab | N | null | 300016795 | CETUXIMAB |
| 300006480 | 300004576 | 1.62 | 53.8 | null | 2016-07-26 | 2016-10-28 | Carboplatin + Etoposide IV 3 day | N | N | 300016805 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006481 | 300004578 | 1.63 | null | Curative (C) | 2016-02-15 | 2016-04-18 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300016811 | CISPLATIN |
| 300006482 | 300004579 | 1.67 | 68.5 | Curative (C) | null | 2016-09-01 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016814 | CISPLATIN |
| 300006483 | 300004582 | null | null | Curative (C) | 2017-07-29 | 2017-08-15 | AML 19 TRIAL | N | null | 300016818 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006484 | 300004583 | 1.8 | 110.5 | Neo-adjuvant (N) | 2016-01-16 | 2016-01-16 | Folfirinox | 02 | N | 300016821 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006485 | 300004584 | null | 103 | Neo-adjuvant (N) | 2015-03-04 | 2015-03-10 | IPILIMUMAB + NIVOLUMAB | 2 | N | 300016830 | CAPECITABINE + OXALIPLATIN |
| 300006486 | 300006899 | 1.71 | null | Palliative (P) | 2014-05-21 | 2014-06-05 | Cisplatin 7 day | N | null | 300016838 | IPILIMUMAB |
| 300006487 | 300004587 | 1.63 | null | Curative (C) | 2016-06-24 | 2016-06-24 | CAPECITABINE + OXALIPLATIN | 02 | null | 300016844 | CETUXIMAB |
| 300006488 | 300004588 | null | null | Adjuvant (A) | null | 2017-03-15 | ESPAC-4 TRIAL | null | null | 300016844 | CARBOPLATIN + PACLITAXEL |
| 300006489 | 300004589 | 1.78 | 72.2 | Curative (C) | 2015-02-16 | 2015-02-23 | Cetuximab + Radiotherapy Load | N | Y | 300016855 | CAPECITABINE + RT |